<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Evaluation of: Kanaan Z, Rai SN, Eichenberger <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> et al </plain></SENT>
<SENT sid="1" pm="."><plain>Plasma MiR-21: a potential diagnostic marker of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Ann </plain></SENT>
<SENT sid="3" pm="."><plain>Surg </plain></SENT>
<SENT sid="4" pm="."><plain>256(3), 544-551 (2012) </plain></SENT>
<SENT sid="5" pm="."><plain>Few studies have assessed circulating miRNAs in the blood of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients </plain></SENT>
<SENT sid="6" pm="."><plain>In the evaluated article, Kanaan et al. demonstrated that miR-21 may be a promising diagnostic plasma biomarker for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>They assessed miRNAs dysregulated in both tissue and blood samples from patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>A high-throughput microarray was used to first detect miRNAs deregulated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> compared with adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissue </plain></SENT>
<SENT sid="9" pm="."><plain>The three most upregulated and downregulated miRNAs were then measured in blood samples </plain></SENT>
<SENT sid="10" pm="."><plain>Plasma miR-21 was able to correctly identify <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> with 90% specificity and sensitivity </plain></SENT>
<SENT sid="11" pm="."><plain>In this article, we have considered the use of miRNAs as blood-based biomarkers for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>